Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022

Go back to Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022
(NASDAQ: BNGO) Delayed: 1.13 -0.05 (4.24%)
Previous Close $1.18    52 Week High $ 
Open $1.18    52 Week Low $ 
Day High $1.18    P/E N/A 
Day Low $1.10    EPS $ 
Volume 251,891